Skip to search.
 TSX Up 0.11% TSX Ventures Down 0.30%

Incyte Corporation (INCY)

-NasdaqGS
81.90 Down 0.08(0.10%) Aug 23, 4:00PM EDT
Prev Close:81.98
Open:82.73
Bid:72.60 x 100
Ask:85.70 x 700
1y Target Est:98.71
Beta:0.654511
Earnings Date:Nov 1 - Nov 7 (Est.)
Day's Range:80.48 - 83.25
52wk Range:55.00 - 133.62
Volume:1,256,692
Avg Vol (3m):1,086,100
Market Cap:15.40B
P/E (ttm):222.55
EPS (ttm):0.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYDown 0.10%15.40B
CELGDown 0.17%88.37B
AMGNUp 0.03%130.51B

Key Statistics

Forward P/E (1 yr):60.22
P/S (ttm):16.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.18
Quarterly EPS Est (Sep-16) :-0.04
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):7.64

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback